[
    {
        "url": "https://www.yalemedicine.org/news/covid-vaccine-for-ages-5-to-11",
        "title": "COVID-19 Vaccine Authorized For Kids Ages 5 to 11: What Parents Need to Know",
        "summary": "The CDC has authorized Pfizer-BioNTech's COVID-19 vaccine for children aged 5 to 11, with distribution starting in October 2021. The vaccine is given under emergency use authorization and has shown 90.7% effectiveness in preventing symptomatic COVID-19. Although side effects are similar to those seen in adolescents, they are generally milder. The vaccine has been found to be safe, with no severe illnesses reported in trials, and is considered beneficial in reducing the spread of COVID-19, even though children typically experience milder symptoms. Pfizer’s vaccine dose for children is smaller than for adults, yet produces a strong immune response. Experts stress that vaccinating children helps protect both them and vulnerable family members, and contributes to community immunity. While vaccination is encouraged, it remains essential for parents to consult with healthcare providers due to the prevalence of misinformation.",
        "snippet": "Medical experts address common questions and concerns about COVID-19 vaccines for young children.The Centers for Disease Control and Prevention (CDC) recommends Pfizer-BioNTech’s COVID-19 vaccine for children ages 5 to 11.."
    },
    {
        "url": "https://www.yahoo.com/news/fact-check-review-pfizer-vaccine-170008690.html",
        "title": "Fact-check: Is review of Pfizer vaccine for children under age 5 based ...",
        "summary": "The review of Pfizer's COVID-19 vaccine for children under age 5 is based in science, despite claims to the contrary. U.S. Rep. Chip Roy argued that Pfizer's efforts to seek authorization are without scientific basis, citing incomplete data from initial trials. However, Pfizer is actively conducting a clinical trial involving thousands of children to evaluate the vaccine's safety and efficacy. It has also amended the study to evaluate a three-dose regimen after two doses did not yield expected immunity in children ages 2 to 5. The FDA's decision to consider emergency use for this vaccine would involve thorough scientific data assessment. Experts emphasize that the vaccine development and clinical trials follow rigorous procedures. The urgency of authorizing a vaccine for young children arises from the increased transmissibility of the omicron variant and its impact on children. The FDA aims to ensure safety and efficacy through its review process.",
        "snippet": "In a Feb. 1 Tweet, Roy wrote, 'Literally using the force of government and the culture of fear to jab children under 5  with zero basis in science  to make billions of dollars. Shameful ..."
    },
    {
        "url": "https://www.houstonchronicle.com/politics/texas/politifact/article/Fact-check-Texas-Republican-falsely-claims-COVID-16926159.php",
        "title": "Rep. Chip Roy (R-Texas) falsely claims COVID vaccine for young kids isn ...",
        "summary": "Rep. Chip Roy (R-TX) falsely claimed that Pfizer's effort to authorize a COVID-19 vaccine for children under 5 has 'zero basis in science' and is driven by profit. His statement was based on concerns about insufficient immunity from a two-dose regimen in initial trials. However, Pfizer's clinical trials, involving thousands of children globally, are designed to assess vaccine safety and effectiveness, and the FDA's authorization would be based on a thorough review of scientific data. The urgency for vaccination stems from the omicron variant's impact, as children, though less likely to experience severe symptoms, can still get infected and spread the virus. The claim is rated 'Pants on Fire' as it is factually incorrect",
        "snippet": "In a Feb. 1 Tweet, Roy wrote, 'Literally using the force of government and the culture of fear to jab children under 5  with zero basis in science  to make billions of dollars. Shameful, @pfizer..."
    },
    {
        "url": "https://www.texasstandard.org/stories/fact-check-how-accurate-is-congressman-chip-roys-claim-that-pfizer-vaccine-for-kids-under-age-5-has-zero-basis-in-science/",
        "title": "Fact check: How accurate is Congressman Chip Roys claim that Pfizer ...",
        "summary": "Texan Congressman Chip Roy claimed in a tweet that Pfizer's effort to get FDA authorization for its COVID-19 vaccine for children under 5 has 'zero basis in science.' Roy criticized the move as motivated by profit rather than scientific evidence. He referenced a New York Times article about Pfizer and BioNTech's request, noting they're evaluating a three-dose regimen for young children. The validity of Roy's claim was investigated by PolitiFact Texas.",
        "snippet": "Roy linked to a Jan. 31 New York Times article reporting this move ahead of Pfizer and BioNTechs expected request. Pfizer is seeking authorization for a two-dose regimen while evaluating how well three doses work. Does Pfizers effort to seek authorization for its vaccine for the youngest children have zero basis in science?"
    },
    {
        "url": "https://thehill.com/policy/healthcare/3611949-pfizer-covid-19-vaccine-73-percent-effective-in-children-under-5/",
        "title": "Pfizer COVID-19 vaccine 73 percent effective in children under 5",
        "summary": "The Pfizer COVID-19 vaccine was reported to be 73.2% effective in preventing symptomatic disease in children under 5, based on a study involving 34 cases during the circulation of the Omicron BA.2 subvariant. The vaccine's authorization, granted in June, followed a delay to study the impact of a third dose, as two doses were deemed insufficient. Pfizer is also developing a vaccine targeting the BA.5 variant for children under 12, similar to its approach for older age groups. Despite these findings, vaccine uptake among children under 5 remains low, with only about 5% vaccinated, highlighting challenges in persuading parents to immunize their young children.",
        "snippet": "Pfizers COVID-19 vaccine was 73.2 percent effective against the disease in children under 5, the company said Tuesday. The company touted the data as reinforcing the importance of the vaccine, wÃ¢Â€Â¦"
    }
]